Disease Areas
USPSTF Now Recommends Colorectal Cancer Screening Beginning at Age 45
The US Preventive Services Task Force had previously recommended that average-risk adults begin colorectal cancer screening at age 50.
DiaSorin Q1 Revenues Rise 53 Percent on SARS-CoV-2 Testing Demand
The company said that its Q1 revenue growth was driven in part by SARS-CoV-2 test revenues of €102.0 million, booked mainly in the US, Canada, and Europe.
DermTech Q1 Revenues up 62 Percent
The firm processed approximately 9,400 billable samples in Q1, a 62 percent increase compared to approximately 5,800 samples in Q1 of 2020.
The company is developing tests for ovarian mass monitoring and endometriosis that it hopes will expand its addressable market beyond that targeted by OVA1.
Lucira Health Posts $4.5M in Sales in First Quarter as Publicly Traded Firm
The firm had a net loss of $13.3 million, or $.58 per share, in Q1 2021 compared to a net loss of $1.7 million, or $.76 per share, a year ago.
May 13, 2021
May 11, 2021
Exagen Q1 Revenues Grow 10 Percent
May 11, 2021
May 10, 2021
Castle Biosciences Q1 Revenues Up 31 Percent
May 7, 2021
May 7, 2021